Medical and Pharmaceutical Ultragenyx plunges after-hours from rare disease drug trial failure Angelman syndrome is a rare genetic nervous system disorder causing severe developmental delay Rowan DunneSeptember 3, 2026
Bitcoin Super League skyrockets from Bitcoin investment merger with Metaplanet Superplanet is born Rowan DunneAugust 19, 2026
Technology Serve Robotics didn’t expect Uber to sell its entire stake Divestment coincides with delivery volumes through Uber falling for first time Rowan DunneAugust 13, 2026
Medical and Pharmaceutical Replimune tanks on FDA concerns about its skin cancer therapy Shares slid by more than 37% at the intraday low on Tuesday Rowan DunneJuly 29, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Cannabis Tilray’s medical cannabis division enters Panama with CBD shipments The nation's legal sector is small and growing slowly Rowan DunneJuly 13, 2026
Medical and Pharmaceutical ClearOne skyrockets from neurotech pivot, merger with Cortigent Cortigent uses brain and retina implant tech to help blind people navigate better Rowan DunneJuly 8, 2026
Technology Social tech company Triller closes 296% higher on SpaceX treasury strategy The investment follows financial turbulence and a 1-for-10 reverse stock split Rowan DunneJune 26, 2026
Medical and Pharmaceutical Tumour freezing specialist IceCure Medical skyrockets from latest successes The Israeli medtech company has been helping breast cancer patients avoid surgery Rowan DunneJune 18, 2026
AI and Autonomy Quantinuum targets USD$1.05B Nasdaq IPO in major quantum computing debut Quantinuum could achieve a fully diluted valuation near USD$12.7 billion Joseph MortonMay 27, 2026